clindamycin has been researched along with Obesity, Morbid in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Atkinson, SN; Barron, M; Fernando, DG; Kindel, TL; Kirby, JR; Saravia, FL | 1 |
Goldblatt, MI; Gould, JC; Helm, MC; Higgins, RM; Kindel, TL; Patz, JJ | 1 |
Al Asad, M; Khaleeq, G; Mohyuddin, GR; Scratchko, L | 1 |
1 trial(s) available for clindamycin and Obesity, Morbid
Article | Year |
---|---|
A single, peri-operative antibiotic can persistently alter the post-operative gut microbiome after Roux-en-Y gastric bypass.
Topics: Adult; Anti-Bacterial Agents; Clindamycin; Female; Gastric Bypass; Gastrointestinal Microbiome; Humans; Male; Middle Aged; Obesity, Morbid; Prospective Studies; RNA, Ribosomal, 16S | 2023 |
2 other study(ies) available for clindamycin and Obesity, Morbid
Article | Year |
---|---|
Peri-operative, intravenous clindamycin may improve the resolution rate of hypertension after Roux-en-Y gastric bypass in morbidly obese patients.
Topics: Administration, Intravenous; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Clindamycin; Female; Gastric Bypass; Gastrointestinal Microbiome; Humans; Hypertension; Male; Middle Aged; Obesity, Morbid; Postoperative Complications; Retrospective Studies | 2019 |
Acute generalized exanthematous pustulosis with multiple organ dysfunction syndrome.
Topics: Acute Generalized Exanthematous Pustulosis; Aged; Anti-Bacterial Agents; Ceftriaxone; Cellulitis; Chronic Disease; Clindamycin; Erythema; Female; Fluid Therapy; Humans; Hypotension; Lower Extremity; Lymphedema; Multiple Organ Failure; Obesity, Morbid; Vancomycin; Vasoconstrictor Agents | 2013 |